New drug trial offers hope for lupus patients with kidney damage
NCT ID NCT07229742
Summary
This study is testing whether an experimental injection called SHR-2173 can help control kidney inflammation in people with active lupus nephritis. Fifty-one participants will receive either the drug or a placebo to compare how well it reduces protein in urine and improves kidney function. The goal is to see if this treatment can better manage this serious complication of lupus.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACTIVE LUPUS NEPHRITIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
The General Hospital of the Eastern Theater Command of the People's Liberation Army of China
RECRUITINGNanjing, Jiangsu, 210002, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.